LH:NYSE
Labcorp Holdings Inc
370,88 $
0,00%
(0,00) 1 d.
370,90 $
arrow_upward
+0,01% (+0,020)todayPirmstirdzniecības
Slēgts: 10. nov., 16:00:03 GMT-5 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: LH…
Tirgus kapitalizācija
30,12 mljrd.
Vid. apjoms
731,35 tūkst.
Apjoms
83,00
Dividende
0,78%
Ceturkšņa dividendes
0,72 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. maijs
Cenas/peļņas attiecība
30,42
Augstākā 52 ned.
373,76 $
Zemākā 52 ned.
245,00 $
Peļņa uz vienu akciju
12,19 $
Beta
0,87
Apgrozībā esošās akcijas
81,20 milj.
Darbinieku skaits
71 tūkst.
Tirgus kapitalizācija
30,12 mljrd.
Vid. apjoms
731,35 tūkst.
Apjoms
83,00
Dividende
0,78%
Ceturkšņa dividendes
0,72 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. maijs
Cenas/peļņas attiecība
30,42
Augstākā 52 ned.
373,76 $
Zemākā 52 ned.
245,00 $
Peļņa uz vienu akciju
12,19 $
Beta
0,87
Apgrozībā esošās akcijas
81,20 milj.
Darbinieku skaits
71 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
HealthExec
·
pirms 16 stundām
Labcorp buys specialty drug testing lab company for $375M
Zacks
·
pirms 19 stundām
Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?
Yahoo Finance
·
pirms 20 stundām
Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?
News Corp
·
pirms 1 dienas
Labcorp Holdings Inc. stock rises Monday, still underperforms market
Profils
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Par “Labcorp Holdings Inc”
ĢenerāldirektorsAdam H. Schechter
Darbinieki71 tūkst.
Dibināšanas datums1978
Galvenais birojsBērlingtona, Ziemeļkarolīna, Amerikas Savienotās Valstis
SektorsHealth Care
NozareHealth care provider
Tīmekļa vietnelabcorp.com